% | $
Quotes you view appear here for quick access.

Cellceutix Corporation Message Board

  • lookoutgrady lookoutgrady Jan 1, 2013 7:55 AM Flag

    Technically a buy pattern is emerging

    A bullish reversal pattern has emerged from the selling pressure over the last view days. It will trigger the short sellers to cover their short positions and may also trigger the next stage up. Now 2 and 2.4 represent resistance, above that is clear skies. However CTIX is mainly driven by news, which can trump the technical aspects.

    A NSDQ listing certainly could mean a double from the current levels, if CTIX would succeed in listing.

    Overall it seems CTIX has a lot of good stories to tell in 2013

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • mikek4848 Jan 1, 2013 8:17 AM Flag

      To expand on that BUY pattern a little and good news to come. Here is what I look to see by JUNE 2013.
      PHASE 2/3 to be completed and successful by end of May for PRURISUL (worth BILLIONS)
      CTIX to have it UPLISTING
      Trial studies on KEVETRIN to have confirmed its effect on p53 in humans plus a measureable tumor shrinkage in study participants (in time worth many BILLIONS)

      After June will still have many good news days as thier are still 6 other drugs in the pipeline and expect that PRURISOL success to , one way or another, PAY FOR IT ALL

      In six months from NOW those holding even 1k of CTIX currently and holding will be beyond happy

      Sentiment: Strong Buy

      • 2 Replies to mikek4848
      • I would expect that for each of the good news release a huge spike will happen due to the large among of short seller trying to cover their shorts. It's too bad that there are no statistics on CTIX, and one of the advantages of being listed on a major board like the NSDQ is the more regulated trading environment.

        I agree that in the month to come there will be steady release of good news.

        Those making a case about valuation should consider future potential of each of the drugs in the pipeline. Even with some delusion due to the need of financing the stock could be trading easily in the mid 20's by year end, and on a three year time frame around 160, if the company executes well. Do your own DD. I was skeptical first, but I did my DD and I'm very comfortable holding here.

        Sentiment: Strong Buy

      • Agreed, excellent risk/reward ratio...many catalysts afoot

        Sentiment: Strong Buy

1.28-0.03(-1.92%)Sep 26 3:25 PMEDT